Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma

Expert Review of Respiratory Medicine

Volumn 2, Issue 2, 2008, Pages 161-166

  Paggiaro, Pierluigi ^a   Nicolini, Gabriele ^b   Papi, Alberto ^c  

^a UNIVERSITY OF PISA   (Italy)

^b CHIESI FARMACEUTICI S P A   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Asthma; Beclomethasone dipropioriate; Combination therapy; Extrafine; Formoterol; Hydrofluoroalkane formulation; Modulite; Technology

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT PLUS CORTICOSTEROID; BUDESONIDE PLUS FORMOTEROL; CHLOROFLUOROCARBON; CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; LONG ACTING DRUG; NORFLURANE; PLACEBO;

ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; HUMAN; HYDROCORTISONE BLOOD LEVEL; METERED DOSE INHALER; PARTICLE SIZE; POWDER INHALER; SINGLE DRUG DOSE; SYMPTOM;

EID: 47249145250     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2.2.161     Document Type: Article

References (26)

1. Global Initiative for Asthma, National Institute of Health, National Heart Lung and Blood Institute, NHLBI/WHO Workshop Report. Global strategy for asthma management and prevention. NHLBI/WHO workshop report no. 02-3659 January 1995, updated 2006.
2. 2-agonists and inhaled steroids versus higher dose of inhaled steroids In children and adults with persistent asthma. Cochrane Database Syst. Rev. 19(4), CD005533 (2005).
3. Reynolds NA, Lyseng-Williamson KA, Wiseman LR. Inhaled salmeterol/ fluticasone propionate: a review of its use in asthma. Drugs 65, 1715-1734 (2005).
4. Goldsmith DR, Keating GM. Budesonide/formoterol: a review of its use in asthma. Drugs 64, 1597-1618 (2004).
5. O'Byrne PM. Acute asthma intervention: insights from the STAY study. J. Allergy Clin. Immunol. 119, 1332-1336 (2007).
6. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 368, 744-753 (2006).
7. Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J. Allergy Clin. Immunol. 112, 29-36 (2003).
8. 2-agonists and corticosteroids. Eur. Respir. J. 19, 182-191 (2002).
9. Rosenhall L, Elvstrand A, Tilling B et al. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. Respir. Med. 97, 702-708 (2003).
10. Bouros D, Bachlitzanakis N, Kottakis J et al. Formoterol and beclometasone versus higher dose beclometasone as maintenance therapy in adult asthma. Eur. Respir. J. 14, 627-632 (1999).
11. Mitchell C, Jemkins C, Scicchitano R et al. Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than higher doses of corticosteroids in moderate-to-severe asthma. Pulm. Pharmacol. Ther. 16, 299-306 (2003).
12. Dhillon S, Keating GM. Beclometasone dipropionate/formoterol in an HFA-propelled pressurised metered-dose inhaler. Drugs 66, 1475-1483 (2006).
13. Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm. Pharmacol. Ther. 20, 290-303 (2007).
14. Lewis D, Johnson S, Meakin BJ et al. Presented at: Respiratory Drug Delivery VI. Hilton Head, SC, USA, 3-7 May 1998.
15. Profita M, Gagliardo R, Di Giorgi R et al. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. Allergy 60, 323-329 (2006).
16. Descalzi D, Folli C, Nicolini G et al. Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. Allergy 63(4), 432-437 (2008).
17. Vanden Burgt J. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J. Allergy Clin. Immunol. 106, 1209-1226 (2000).
18. Poli G, Acerbi D, Nollevaux F. Pharmacokinetics and pharmacodynamics of a new beclometasone dipropionate and formoterol CFC-free fixed combination in healthy volunteers. Eur. Respir. J. 28(Suppl. 50), P3869 (2006) (Abstract).
19. Bonnet-Gonod F, Kottakis I, Ballabio M et al. Superior efficacy of a low dose of a new fixed combination of beclometasone dipropionate/ formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study. 16th Annual Congress of the European Respiratory Society. Eur. Respir. J. 28(Suppl. 50), P1237 (2006) (Abstract).
20. Bonnet-Gonod F, Kottakis I, Hofman T et al. Beclometasone dipropionate/formoterol in a single inhaler improves lung function and clinically meaningful outcomes in moderate to severe asthma. 16th Annual Congress of the European Respiratory Society. Eur. Respir. J. 28(Suppl. 50), P1230 (2006) (Abstract).
21. Papi A, Paggiaro PL, Nicolini G et al. Beclometasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur. Respir. J. 29, 682-689 (2007).
22. Papi A, Paggiaro P, Nicolini G et al. Beclometasone/formoterol vs. fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 62, 1182-1188 (2007).
23. Derendorf H, Nave R, Drollmann A et al. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur. Respir. J. 28, 1042-1050 (2006).
24. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J. Allergy Clin. Immunol. 109(2 Suppl.), S447-S460 (2002).
25. Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir. Med. 95, 703-719 (2001).
26. McCormark PL, Lyseng-Williamson KA. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. Drugs 67, 2407-2431 (2007).